Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Russo

Showing results (281-290 of 357) with videos related to

Pageof 36
Sort By:
World Journal of Urology|March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomyAndrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
Urologic Oncology|August 29, 2016
The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive modelsBrandon J Manley, Daniel M Tennenbaum, Emily A Vertosick, et al.
Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.
Cancer Medicine|August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional samplingAlexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Cancer|July 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinomaAndrew W Silagy, Ritesh R Kotecha, Stanley Weng, et al.
Annals of Neurology|February 9, 2002
Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlationCornelius F Boerkoel, Hiroshi Takashima, Carlos A Garcia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.
The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.
European Urology|August 24, 2015
An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial NephrectomyMassimiliano Spaliviero, Bing Ying Poon, Christoph A Karlo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research networkA Ari Hakimi, Irina Ostrovnaya, Boris Reva, et al.
Pageof 36

Showing results (281-290 of 357) with videos related to

Sort By:
Pageof 36
World Journal of Urology|March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomyAndrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
Urologic Oncology|August 29, 2016
The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive modelsBrandon J Manley, Daniel M Tennenbaum, Emily A Vertosick, et al.
Cancers|December 11, 2025
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell CarcinomaAndrea Lopez Sanmiguel, Yash S Khandwala, Kuo Fengshen, et al.
Cancer Medicine|August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional samplingAlexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Cancer|July 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinomaAndrew W Silagy, Ritesh R Kotecha, Stanley Weng, et al.
Annals of Neurology|February 9, 2002
Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlationCornelius F Boerkoel, Hiroshi Takashima, Carlos A Garcia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcomePaari Murugan, Liwei Jia, Renzo G Dinatale, et al.
The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.
European Urology|August 24, 2015
An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial NephrectomyMassimiliano Spaliviero, Bing Ying Poon, Christoph A Karlo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research networkA Ari Hakimi, Irina Ostrovnaya, Boris Reva, et al.
Pageof 36